Kontafarma China Holdings Limited (HKG:1312)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.0340
+0.0010 (3.03%)
Sep 18, 2026, 3:59 PM HKT

Kontafarma China Holdings Financials Overview

Millions HKD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
845.33914.71897.52809.11894.06803.27
Revenue Growth
-7.58%1.92%10.93%-9.50%11.30%-20.40%
Gross Profit
437.76513.64516.16471.29506.22396.18
Operating Income
-61.09-44.9-45.23-92.33-84.41-97.71
Net Income
-212.8-427.85-75.54-28.84-41.55-15.05
Earnings Per Share
-0.04-0.08-0.01-0.01-0.01-0.00
EPS Growth
------

Revenue by Segment

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Fitness Business
178.96197.74215.44201.98171.16161.28
Pharmaceutical Business
666.37716.97682.09607.13722.9641.99
Total
845.33914.71897.52809.11894.06803.27

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
67.6266.0690.5987.66142.6183.96
Total Debt
189.76203.68297.19333.82590.72728.95
Net Cash (Debt)
-122.14-137.62-206.6-246.16-448.13-544.99
Net Cash Growth
------
Net Cash Per Share
-0.02-0.02-0.04-0.04-0.08-0.10

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
38.876.6847.0537.12-2.1775.07
Capital Expenditures
-19.64-23.52-13.64-23.92-51.68-67.19
Free Cash Flow
19.1553.1533.4113.2-53.847.88
Free Cash Flow Growth
-63.97%59.10%153.17%---84.57%

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
51.79%56.15%57.51%58.25%56.62%49.32%
Operating Margin
-7.23%-4.91%-5.04%-11.41%-9.44%-12.16%
Pretax Margin
-22.93%-49.71%-10.92%-5.43%-13.17%-6.78%
Profit Margin
-25.17%-46.77%-8.42%-3.56%-4.65%-1.87%
FCF Margin
2.27%5.81%3.72%1.63%-6.02%0.98%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
P/FCF Ratio
9.923.054.3515.25-34.77
PS Ratio
0.220.180.160.250.280.34